Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Covid-19 in a Child With Primary Antibody Deficiency Publisher



Ahanchian H1 ; Moazzen N1, 2 ; Sezavar M3 ; Khalighi N1 ; Khoshkhui M1 ; Aelami MH4 ; Motevalli Haghi NS1 ; Rezaei N5, 6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. Clinical Research Development Unit of Akbar hospital, Mashhad University of medical Sciences, Mashhad, Iran
  3. 3. Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  4. 4. Department of Pediatrics and Hand Hygiene and Infection Control Research Center, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
  5. 5. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: Clinical Case Reports Published:2021


Abstract

Although presentation of COVID-19 in patients with immunodeficiency could be mild, it should not be missed, while early diagnosis and appropriate treatment can survive infected patients. Because even severe infections in PID patients may be presented with few symptoms and signs, this diagnosis should be considered in those immunocompromised patients who have exacerbating preexisting symptoms. © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Other Related Docs
10. Interdisciplinary Approaches to Covid-19, Advances in Experimental Medicine and Biology (2021)
11. Microfluidic Devices for Detection of Rna Viruses, Reviews in Medical Virology (2021)
12. Health and Art (Heart): Integrating Science and Art to Fight Covid-19, Advances in Experimental Medicine and Biology (2021)
14. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
15. Covid-19 in Patients With Cancer, Advances in Experimental Medicine and Biology (2021)
16. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
17. Nutrition and Immunity in Covid-19, Advances in Experimental Medicine and Biology (2021)
22. Covid-19 and Its Global Economic Impact, Advances in Experimental Medicine and Biology (2021)
24. Neurologic Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
25. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
29. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
34. Immunotherapy for Sars-Cov-2: Potential Opportunities, Expert Opinion on Biological Therapy (2020)
36. Monoclonal Antibody As a Potential Anti-Covid-19, Biomedicine and Pharmacotherapy (2020)
41. Covid-19 and Medical Biotechnology, Avicenna Journal of Medical Biotechnology (2020)
42. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
49. New Presentation of Cd27 Deficiency; Coronary Ectasia and Covid-19, Iranian Journal of Allergy# Asthma and Immunology (2023)